Tocilizumab: molecular intervention therapy in children with systemic juvenile idiopathic arthritis-Reference-Cited by-同舟云学术

Tocilizumab: molecular intervention therapy in children with systemic juvenile idiopathic arthritis

Published:2010-09 Issue:5 Volume:6 Page:735-743
ISSN:1744-666X
Container-title:Expert Review of Clinical Immunology
language:en
Short-container-title:Expert Review of Clinical Immunology

Author:

Yokota Shumpei,Kishimoto Tadamitsu

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.1586/eci.10.41

Reference61 articles.

1. Cassidy JT, Petty RE. Juvenile idiopathic arthritis. In:Textbook of Pediatric Rheumatology (5thEdition). Cassidy JT, Petty RE (Eds). WB Saunders, PA, USA, 291–303 (2005).

2. Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-γ-producing lymphocytes and IL-6- and TNF-α-producing macrophages

3. Long-term follow-up of 246 adults with juvenile idiopathic arthritis: predictive factors for mood and pain

4. How the study of children with rheumatic diseases identified interferon-α and interleukin-1 as novel therapeutic targets

5. Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficacy of canakinumab treatment for undifferentiated autoinflammatory diseases: the data of a retrospective cohort two-centered study;Frontiers in Medicine;2023-11-15

2. Does Interleukin-6 Bridge SARS-CoV-2 With Virus-Associated Cancers?;Journal of Immunotherapy and Precision Oncology;2021-01-29

3. Juvenile Idiopathic Arthritis, Systemic Lupus Erythematosus and Juvenile Dermatomyositis;Harper's Textbook of Pediatric Dermatology;2019-11-20

4. Intravenous dosing of tocilizumab in patients younger than two years of age with systemic juvenile idiopathic arthritis: results from an open-label phase 1 clinical trial;Pediatric Rheumatology;2019-08-22

5. Efficacy of biologic therapy across individual juvenile idiopathic arthritis subtypes: A systematic review;Seminars in Arthritis and Rheumatism;2017-04